医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Hoya Reports Second Quarter Results; Record Half Year Results

2017年10月27日 PM07:31
このエントリーをはてなブックマークに追加


 

TOKYO

Hoya Corporation (TOKYO: 7741) today announced financial results for the second quarter ended September 30, 2017.

During the quarter, revenue of the HOYA Group increased 18.2% year on year, reaching 135,772 million yen. Pre-tax profit amounted to 32,868 million yen with 26,767 million yen in profit, representing increases of 3.9% and 7.9%, respectively.

In the Life Care segment, sales of eyeglass lenses rose, mainly overseas and in response to business acquisitions. Medical endoscopes experienced improved sales, pushed mainly by performance in Europe and Asia. New products drove sales of intraocular lenses as well. As a result, the Life Care segment as a whole reported higher sales year on year.

The Information Technology segment also reported higher revenues year on year, driven by stronger demands in semiconductor devices and glass substrates for hard disk drives. Imaging-related product sales increased as well due to an expansion of new applications.

For the six months ended September 30, 2017, HOYA posted record revenues of 262,930 million yen and record profit for the term of 51,960 million yen, representing increases of 14.3% and 21.4%, respectively.

“The Life Care segment delivered sales increase of 9.4% without exchange gain this quarter,” said Hiroshi Suzuki, president and chief executive officer of HOYA. “We expect the segment profitability to improve in the second half as post-merger integration completes.”

HOYA also announced the interim dividends of 30 yen per share of common stock.

 

Summary of Consolidated Financial Statement

(Millions of Yen: Rounded to the nearest million)
      Three months ended   Variance   Six months ended   Variance
          Sept./16   Sept./17 (%) Sept./16   Sept./17 (%)
Revenue 114,865 135,772 18.2 230,030 262,930 14.3
Profit before tax 31,637 32,868 3.9 53,911 63,416 17.6
Profit for the term 24,819 26,767 7.9 42,797 51,960 21.4
Basic earnings per share(yen)   63.42   70.11     108.62   134.81  

*Results are preliminary and unaudited.

 

The full reports are available at: www.hoya.com

About HOYA

Founded in 1941 in Tokyo, Japan, Hoya is a global med-tech company and the leading supplier of innovative high-tech and medical products. Hoya is active in the fields of healthcare and information technology providing eyeglasses, medical endoscopes, intraocular lenses, optical lenses as well as key components for semiconductor devices, LCD panels and HDDs. With over 150 offices and subsidiaries worldwide, Hoya currently employs a multinational workforce of 36,000 people. For more information, please visit http://www.hoya.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20171027005295/en/

CONTACT

Hoya Group
Akiko Chiba, +81-3-6911-4824
Public Relation
HOYA-pr@hoya.com

同じカテゴリーの記事 

  • La Jolla Institute for Immunology and RevolKa started a Research Collaboration
  • U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
  • ESCMID Global 2024: Shionogi presents real-world data demonstrating efficacy of Fetcroja® / Fetroja® (cefiderocol) in critically ill patients with certain difficult-to-treat bacterial infections
  • Renesas’ New FemtoClock™ 3 Timing Solution Delivers Industry’s Lowest Power and Leading Jitter Performance of 25fs-rms
  • 成人向け予防接種プログラムは初期投資の19倍もの社会経済的価値をもたらすとの新レポートを発表